Literature DB >> 17280689

SLURP-1 and -2 in normal, immortalized and malignant oral keratinocytes.

Juan Arredondo1, Alexander I Chernyavsky, Sergei A Grando.   

Abstract

The secreted mammalian Ly-6/urokinase plasminogen activator receptor-related proteins (SLURP)-1 and -2 are produced by keratinocytes comprising the mucocutaneous epithelium. They regulate in autocrine and paracrine ways cell growth and differentiation through the nicotinic acetylcholine receptors (nAChRs) expressed on the plasma membrane. Keratinocyte nAChRs are targeted by tobacco-derived carcinogenic nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and N'-nitrosonornicotine (NNN) that can induce tumorigenic transformation of Het-1A keratinocytes. In this study we asked if SLURPs could abolish tumorigenic effects of nitrosamines. Preincubation with either recombinant SLURP-1 or -2 in both cases considerably reduced the number of colonies in soft agar, and the number of tumor nodules >0.5 cm in diameter in Nu/Nu mice produced by Het-1A cells treated with nitrosamines. The levels of SLURP-1 and -2 mRNA transcripts in nitrosamine-transformed Het-1A cells as well as in the tumor cell lines SCC-25 and FaDu were significantly (p<0.05) less compared to normal gingival keratinocytes, which are probably the major source of the secreted SLURPs found in a sample of human saliva. The expression of SLURPs was decreased due to gene silencing of different nAChR alpha subunits with small hairpin RNA, suggesting that a positive feedback regulation is altered in malignant cells. Thus, SLURP-1 and -2 are efficient autocrine and paracrine ligands of keratinocyte nAChRs capable of preventing tobacco nitrosamine-induced malignant transformation of oral cells. These "proof-of-concept" preliminary results have salient clinical implications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17280689      PMCID: PMC1929016          DOI: 10.1016/j.lfs.2007.01.003

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  11 in total

Review 1.  Nicotine exposure and bronchial epithelial cell nicotinic acetylcholine receptor expression in the pathogenesis of lung cancer.

Authors:  John D Minna
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

2.  The nicotinic receptor antagonists abolish pathobiologic effects of tobacco-derived nitrosamines on BEP2D cells.

Authors:  Juan Arredondo; Alex I Chernyavsky; Sergei A Grando
Journal:  J Cancer Res Clin Oncol       Date:  2006-07-12       Impact factor: 4.553

3.  A receptor-mediated mechanism of nicotine toxicity in oral keratinocytes.

Authors:  J Arredondo; V T Nguyen; A I Chernyavsky; D L Jolkovsky; K E Pinkerton; S A Grando
Journal:  Lab Invest       Date:  2001-12       Impact factor: 5.662

4.  SLURP-2: A novel cholinergic signaling peptide in human mucocutaneous epithelium.

Authors:  Juan Arredondo; Alexander I Chernyavsky; David L Jolkovsky; Robert J Webber; Sergei A Grando
Journal:  J Cell Physiol       Date:  2006-07       Impact factor: 6.384

5.  Receptor-mediated tobacco toxicity: regulation of gene expression through alpha3beta2 nicotinic receptor in oral epithelial cells.

Authors:  Juan Arredondo; Alexander I Chernyavsky; Lisa M Marubio; Arthur L Beaudet; David L Jolkovsky; Kent E Pinkerton; Sergei A Grando
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

6.  Biological effects of SLURP-1 on human keratinocytes.

Authors:  Juan Arredondo; Alexander I Chernyavsky; Robert J Webber; Sergei A Grando
Journal:  J Invest Dermatol       Date:  2005-12       Impact factor: 8.551

7.  Selective inhibition of enterovirus 71 replication by short hairpin RNAs.

Authors:  Wen-Wen Lu; Yueh-Ying Hsu; Jyh-Yuan Yang; Szu-Hao Kung
Journal:  Biochem Biophys Res Commun       Date:  2004-12-10       Impact factor: 3.575

8.  Nicotinic receptors mediate tumorigenic action of tobacco-derived nitrosamines on immortalized oral epithelial cells.

Authors:  Juan Arredondo; Alex I Chernyavsky; Sergei A Grando
Journal:  Cancer Biol Ther       Date:  2006-05-13       Impact factor: 4.742

9.  SLURP-2, a novel member of the human Ly-6 superfamily that is up-regulated in psoriasis vulgaris.

Authors:  Hitomi Tsuji; Koichi Okamoto; Yasunari Matsuzaka; Hajime Iizuka; Gen Tamiya; Hidetoshi Inoko
Journal:  Genomics       Date:  2003-01       Impact factor: 5.736

10.  Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda.

Authors:  Fabrice Chimienti; Ronald C Hogg; Laure Plantard; Caroline Lehmann; Noureddine Brakch; Judith Fischer; Marcel Huber; Daniel Bertrand; Daniel Hohl
Journal:  Hum Mol Genet       Date:  2003-09-23       Impact factor: 6.150

View more
  29 in total

1.  Novel cholinergic peptides SLURP-1 and -2 regulate epithelialization of cutaneous and oral wounds.

Authors:  Alexander I Chernyavsky; Mina Kalantari-Dehaghi; Courtney Phillips; Steve Marchenko; Sergei A Grando
Journal:  Wound Repair Regen       Date:  2011-12-13       Impact factor: 3.617

2.  Nicotinic receptor signaling in nonexcitable epithelial cells: paradigm shifting from ion current to kinase cascade. Focus on "Upregulation of nuclear factor-kappaB expression by SLURP-1 is mediated by alpha7-nicotinic acetylcholine receptor and involves both ionic events and activation of protein kinases".

Authors:  Andrzej Slominski
Journal:  Am J Physiol Cell Physiol       Date:  2010-08-25       Impact factor: 4.249

Review 3.  Is cancer triggered by altered signalling of nicotinic acetylcholine receptors?

Authors:  Hildegard M Schuller
Journal:  Nat Rev Cancer       Date:  2009-02-05       Impact factor: 60.716

Review 4.  Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses.

Authors:  Julie M Miwa; Robert Freedman; Henry A Lester
Journal:  Neuron       Date:  2011-04-14       Impact factor: 17.173

Review 5.  The genetics of substance dependence.

Authors:  Jen-Chyong Wang; Manav Kapoor; Alison M Goate
Journal:  Annu Rev Genomics Hum Genet       Date:  2012-06-11       Impact factor: 8.929

Review 6.  Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery.

Authors:  Henry A Lester; Cheng Xiao; Rahul Srinivasan; Cagdas D Son; Julie Miwa; Rigo Pantoja; Matthew R Banghart; Dennis A Dougherty; Alison M Goate; Jen C Wang
Journal:  AAPS J       Date:  2009-03-12       Impact factor: 4.009

7.  Prostate stem cell antigen is an endogenous lynx1-like prototoxin that antagonizes alpha7-containing nicotinic receptors and prevents programmed cell death of parasympathetic neurons.

Authors:  Martin Hruska; Julie Keefe; David Wert; Ayse Begum Tekinay; Jonathan J Hulce; Ines Ibañez-Tallon; Rae Nishi
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

8.  SLURP-1 modulates corneal homeostasis by serving as a soluble scavenger of urokinase-type plasminogen activator.

Authors:  Sudha Swamynathan; Shivalingappa K Swamynathan
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-28       Impact factor: 4.799

Review 9.  Targeting brain α7 nicotinic acetylcholine receptors in Alzheimer's disease: rationale and current status.

Authors:  Ana Sofía Vallés; María Virginia Borroni; Francisco J Barrantes
Journal:  CNS Drugs       Date:  2014-11       Impact factor: 5.749

10.  Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation.

Authors:  Rodrigo R Resende; Avishek Adhikari
Journal:  Cell Commun Signal       Date:  2009-08-27       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.